How long does it take to receive chemotherapy after ovarian cancer surgery?

Chemotherapy after ovarian cancer surgery usually begins within 3-4 weeks after surgery. The specific time needs to be determined based on the patient's postoperative recovery, pathological staging and doctor's evaluation.

The start time of postoperative chemotherapy is mainly affected by the speed of recovery from surgical trauma. If the patient's wound heals well after surgery, there are no infections or complications, and blood routine, liver and kidney function and other indicators are normal, chemotherapy can usually be started 3 weeks after surgery. For patients who undergo cytoreductive surgery, if there is a large amount of bleeding during the operation or there is damage to organs such as intestines, the recovery period may be extended to 4 weeks. The selection of chemotherapy regimen should refer to the pathological type and stage. For epithelial ovarian cancer, paclitaxel combined with carboplatin is commonly used, while for germ cell tumors, a combination of bleomycin, etoposide, and cisplatin may be used. The patient's physical status needs to be assessed before chemotherapy. Those with an ECOG score of ≤2 are more suitable for chemotherapy.

Chemotherapy time may be adjusted in some special circumstances. If serious complications such as intestinal obstruction or anastomotic leakage occur after surgery, chemotherapy should be considered only after the complications are completely controlled. For elderly patients or patients with underlying diseases, the recovery period may exceed 4 weeks. For BRCA gene mutation carriers, if they plan to combine targeted therapy, the timing of synergy between targeted drugs and chemotherapy needs to be comprehensively evaluated. For patients undergoing intermittent cytoreduction after neoadjuvant chemotherapy, the time to restart postoperative chemotherapy may be shortened to 2 weeks.

Postoperative chemotherapy is a key part of the comprehensive treatment of ovarian cancer, which can effectively remove residual lesions and micro-metastasis. Patients need to maintain a balanced diet, supplement appropriate amounts of high-quality protein such as fish and eggs, and avoid high-fat diets. Strenuous exercise should be avoided within 1 month after surgery, and low-intensity activities such as walking can be performed. Blood routine monitoring is required every week during chemotherapy, and liver and kidney function should be assessed before each cycle. Seek medical attention promptly when bone marrow suppression or gastrointestinal reactions occur. If necessary, adjust the dose of chemotherapy or provide symptomatic and supportive treatment.